Home

Investor Relations

TSX:LEAF: 7.95
0.25 3.05% Volume: 167,786 Pricing delayed 20 minutes June 28, 2017

Company Overview

MedReleaf sets The Medical Grade Standard™ for cannabis in Canada and around the world. The first and only ISO 9001 certified cannabis producer in North America, MedReleaf is a R&D-driven company dedicated to patient care, scientific innovation, research and advancing the understanding of the therapeutic benefits of cannabis. Sourced from around the world and perfected in one of two state of the art facilities in Ontario, MedReleaf delivers a variety of premium products to patients seeking safe, consistent and effective medical cannabis.

Latest News

28 Jun 2017.
MedReleaf Corp. (TSX: LEAF) ("MedReleaf" or the "Company"), Canada's first and only ISO 9001 and ICH-GMP certified cannabis producer, today announced financial and operating results for the fourth quarter and fiscal year ended March 31, 2017 . All amounts expressed are in Canadian dollars unless otherwise noted. "We doubled revenue in fiscal 2017 and we did it profitably – growing Adjusted EBITDA more than threefold," said Neil Closner, CEO of MedReleaf. "With the successful completion of our IPO in June we have $74 million in financing to help fund our strategic growth initiatives including: expanding our capacity more than five times to support up to 35,000 kilograms of production; scaling our domestic business; developing our recreational brand portfolio; and international expansion, which we believe positions MedReleaf well for future growth and profitability." Fourth Quarter and Fiscal Year 2017 Financial Summary Three Months Twelve Months March 31, March 31, CAD$ (in 000s, ...
22 Jun 2017.
MedReleaf Corp. (TSX: LEAF), ("MedReleaf"), Canada's first and only ISO 9001 and ICH-GMP certified cannabis producer, announced today that Donald Courtney has been appointed Chief Operating Officer (COO). As a senior executive, Mr. Courtney brings to MedReleaf over twenty years of global operations and supply chain experience with large multi-national organizations in the wine, food, consumer packaged goods (CPG) and technology sectors. "Wine, technology, food and CPG are all very relevant to the future of the global cannabis industry and we are very pleased to welcome Don to our leadership team given his impressive track record in these industries," said Neil Closner, CEO of MedReleaf.  "Don brings the operational expertise necessary to support our continued growth while maintaining our industry-leading standards of product quality and production excellence." Mr. Courtney brings to MedReleaf a wealth of relevant experience including senior operational roles at Vincor International , ...
19 Jun 2017.
MedReleaf Corp. (TSX: LEAF) ("MedReleaf" or the "Company"), Canada's first and only ISO 9001 certified cannabis producer, announced today that it has become the first medical cannabis producer to receive an International Council on Harmonization certification for Good Manufacturing Practices ("ICH-GMP") for Active Pharmaceutical Ingredients. MedReleaf's wide-ranging ICH-GMP compliance certification covers the Research and Development, Production, Distribution, Processing, Selling, and Destruction of medical cannabis for its Markham facility. Although there are a number of different GMP certifying bodies, the ICH-GMP is the globally accepted standard for the pharmaceutical industry recognized by regulatory authorities around the world including Canada , the United States , EU, Japan , Singapore and Australia . MedReleaf's ICH-GMP certification will support the Company's international growth and commitment to maintaining its position as the Medical Grade Standard in a number of ways, ...